全文获取类型
收费全文 | 1897篇 |
免费 | 8篇 |
专业分类
电工技术 | 18篇 |
化学工业 | 97篇 |
金属工艺 | 5篇 |
机械仪表 | 15篇 |
建筑科学 | 19篇 |
矿业工程 | 3篇 |
能源动力 | 22篇 |
轻工业 | 105篇 |
水利工程 | 3篇 |
石油天然气 | 1篇 |
无线电 | 72篇 |
一般工业技术 | 97篇 |
冶金工业 | 1398篇 |
原子能技术 | 5篇 |
自动化技术 | 45篇 |
出版年
2022年 | 3篇 |
2021年 | 5篇 |
2019年 | 3篇 |
2018年 | 4篇 |
2017年 | 10篇 |
2016年 | 4篇 |
2015年 | 6篇 |
2014年 | 12篇 |
2013年 | 16篇 |
2012年 | 18篇 |
2011年 | 19篇 |
2010年 | 11篇 |
2009年 | 16篇 |
2008年 | 20篇 |
2007年 | 22篇 |
2006年 | 24篇 |
2005年 | 20篇 |
2004年 | 20篇 |
2003年 | 25篇 |
2002年 | 24篇 |
2001年 | 16篇 |
2000年 | 30篇 |
1999年 | 61篇 |
1998年 | 438篇 |
1997年 | 257篇 |
1996年 | 129篇 |
1995年 | 96篇 |
1994年 | 68篇 |
1993年 | 84篇 |
1992年 | 23篇 |
1991年 | 18篇 |
1990年 | 25篇 |
1989年 | 24篇 |
1988年 | 22篇 |
1987年 | 17篇 |
1986年 | 22篇 |
1985年 | 16篇 |
1984年 | 3篇 |
1983年 | 12篇 |
1982年 | 10篇 |
1981年 | 14篇 |
1980年 | 21篇 |
1978年 | 6篇 |
1977年 | 39篇 |
1976年 | 121篇 |
1975年 | 7篇 |
1974年 | 5篇 |
1973年 | 8篇 |
1972年 | 9篇 |
1971年 | 3篇 |
排序方式: 共有1905条查询结果,搜索用时 15 毫秒
21.
HH Henneicke-von Zepelin U Mrowietz L F?rber K Bruck-Borchers C Schober J Huber G Lutz R Kohnen E Christophers D Welzel 《Canadian Metallurgical Quarterly》1993,129(6):713-717
We report the results of a multicentre, double-blind, placebo-controlled study of topical therapy with omega-3-polyunsaturated fatty acids (omega-3-PUFA) in 52 patients suffering from moderate plaque-type psoriasis. In each patient, two similar stable psoriatic plaques served as indicator lesions for the study. One indicator lesion was randomly assigned to treatment with topical preparations of highly purified omega-3-PUFA in one of two concentrations (1 or 10%), and the other was treated with placebo. Efficacy assessment was based on changes in local psoriasis severity index, area involved, erythema, desquamation, induration and pruritus. After 8 weeks of treatment, all indicator lesions had improved significantly, compared with baseline. However, no statistically or clinically relevant differences between the omega-3-PUFA-treated and the placebo-treated lesions were found. Therapy was well tolerated and, apart from one patient who developed perilesional eczema, no clinically relevant adverse events occurred. In conclusion, topical omega-3-PUFA were not effective in a randomized, placebo-controlled, double-blind setting. Results of non-blind trials should be (re-)considered with caution. 相似文献
22.
We have used the fluorescence in situ hybridization (FISH) technique to refine the localization of the cystic fibrosis transmembrane conductance regulator (CFTR) gene on human chromosome 7. The result shows that the gene is most likely located within band q31.3. 相似文献
23.
24.
25.
26.
M Steinhardt HH Thielscher T von Horn R von Horn K Ermgassen D Smidt 《Canadian Metallurgical Quarterly》1996,103(4):136-141
Dairy calves and their dams from the dairy herd of the institute were used for this investigation. Calvings were watch carefully and jugular venous blood samples taken immediately after delivery from the cow and the calf and in the calf at 24 hours and at 48 hours of postnatal age as well were analyzed for T4, FT4, T3 and FT3 by luminescence enzyme immunoassay (LEIA). Higher thyroid values in calves than in their dams could be found increasing short after birth and reaching their highest level within 24 hours of postnatal life. The individual thyroid hormone values at birth and at 24 hours and at 48 hours of age are well correlated meaning the changes during the first days are specific for each calf. Strong correlation between the thyroid hormone values of the cows and those of the calves could be found. Mean values of thyroid hormones were significantly higher in female than in male calves all time but not different in the dams of these calves. 相似文献
27.
28.
29.
OBJECTIVE: Endoscopic surveillance of Barrett's esophagus is commonly practiced to detect malignancy in an early and curable stage. However, the cost-effectiveness of this practice has been questioned. To clarify this issue, we undertook a cost analysis of endoscopic surveillance to detect adenocarcinoma in Barrett's esophagus compared with mammography used to detect occult carcinoma of the breast, a widely accepted cancer surveillance technique. METHODS: The rate of esophageal adenocarcinoma detected by endoscopic surveillance was calculated for Duluth Clinic patients with Barrett's esophagus seen from 1980 to 1995 and compared with published rates. The rate of occult breast cancer detection was calculated for all women undergoing surveillance mammography at the Duluth Clinic for the year 1994 and compared with published rates. Costs for screening studies and therapy for cancer treatment for both cancers were calculated based on clinical results and assumptions regarding outcomes derived from published reports, and the costs were compared. RESULTS: Endoscopic surveillance of 149 patients with benign Barrett's esophagus was performed for a total of 510 patient-yr, during which time seven patients developed adenocarcinoma, an incidence of one case per 73 patient-yr of follow-up. Occult breast cancer was detected in 50 of 12,537 mammograms, a detection rate of 0.4%. The incidences in both cases were comparable to published figures. The costs of detecting a case of adenocarcinoma in Barrett's esophagus and occult breast cancer were $37,928 and $54,513, respectively, and those for treatment resulting in cure were $83,340 and $83,292. Cost per life-yr saved was $4,151 for adenocarcinoma in Barrett's esophagus and $57,926 for breast cancer. CONCLUSION: Endoscopic surveillance of patients with Barrett's esophagus compares favorably with the common practice of surveillance mammography to detect early breast cancer, and should therefore be considered to be as cost-effective as surveillance mammography. 相似文献
30.
JH Noseworthy P O'Brien BJ Erickson D Lee D Sneve GC Ebers GP Rice A Auty WJ Hader A Kirk P Duquette J Carter G Francis L Metz E Shuster 《Canadian Metallurgical Quarterly》1998,51(5):1342-1352
OBJECTIVE: To determine whether sulfasalazine is better than placebo in slowing disability progression in MS. METHODS: In this randomized, double-blind, placebo-controlled phase III trial, 199 patients with active relapsing-remitting (n = 151) or progressive (n = 48) MS were evaluated at 3-month intervals for a minimum of 3 years (94% completed 3 years of follow-up; mean follow-up, 3.7 years). MRI studies were performed at 6-month intervals on a subset of 89 patients. RESULTS: Sulfasalazine failed to slow or prevent disability progression as measured by the primary outcome (confirmed worsening of the Expanded Disability Status Scale [EDSS] score by at least 1.0 point on two consecutive 3-month visits). Sulfasalazine influenced favorably a number of secondary outcomes during the first 18 months of the trial (e.g., annualized relapse rate, proportion of relapse-free patients; progressive subgroup only: rate of EDSS progression at 1 and 2 years, median time to EDSS progression) but these positive findings were not sustained into the second half of the trial. CONCLUSIONS: Sulfasalazine does not prevent EDSS score progression in the subset of MS patients studied by this protocol. Treatments may improve relapse-related outcomes in MS, at least temporarily, without providing sustained slowing of EDSS progression. Phase III MS trials should be of sufficient length to determine a meaningful impact on disease course. 相似文献